Novo Integrated Sciences Announces New President of Novo Healthnet Limited
Summary
With the Company implementing its medical technology applications and rehabilitative sciences growth strategies, Mr. Asher’s expertise in sales, marketing, developing and monetizing programs for combatting metabolic syndrome, and integrating patient-based protocols, products, and services while ensuring positive patient outcomes provides NHL with strong leadership during this critical period of transformation. Robert Mattacchione, the Company’s CEO and Board Chairman, stated, “ James brings an undeniable track record of developing wellness sales strategies and executing on those initiatives with impressive results. Currently, the Company’s revenue is generated solely through its wholly owned Canadian subsidiary, Novo Healthnet Limited (“NHL”), which provides services and products through both clinic and eldercare related operations. NHL’s team of multidisciplinary primary healthcare clinicians and practitioners provide assessment, diagnosis, treatment, pain management, rehabilitation, education and primary prevention for a wide array of orthopedic, musculoskeletal, sports injury, and neurological conditions across various demographics including pediatric, adult, and geriatric populations through NHL’s 16 corporate-owned clinics, a contracted network of 103 affiliate clinics, and 218 eldercare related long-term care homes, retirement homes, and community-based locations in Canada. Investors should not place any undue reliance on forward-looking statements since they involve known and unknown, uncertainties and other factors which are, in some cases, beyond Novo Integrated Sciences control which could, and likely will, materially affect actual results, levels of activity, performance or achievements.